electromed, inc. is a minnesota-based company (nyse mkt: elmd) and the innovative leader in the development, manufacture, and worldwide sales of the smartvest® airway clearance system. the patented system uses high frequency chest wall oscillation (hfcwo), a better-tolerated alternative to chest physiotherapy (cpt), to deliver vigorous, yet comfortable airway clearance treatment for patients battling the consequences of retained secretions. hfcwo has been clinically proven to clear the lungs of excess mucus, improve and reduce lung infections for individuals suffering from various conditions including atelectasis, copd, bronchiectasis, neuromuscular diseases, and cystic fibrosis. electromed, inc. is accredited by the joint commission and is iso 13485:2003 and iso 9001:2008 certified.
Company profile
Ticker
ELMD
Exchange
Website
CEO
Kathleen S. Skarvan
Employees
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
SEC CIK
Corporate docs
IRS number
411732920
ELMD stock data
Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
13 Feb 24
8-K
Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter
13 Feb 24
8-K
Entry into a Material Definitive Agreement
15 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Nov 23
S-8
Registration of securities for employees
30 Nov 23
8-K
Submission of Matters to a Vote of Security Holders
15 Nov 23
10-Q
2024 Q1
Quarterly report
7 Nov 23
8-K
Electromed, Inc. Announces Fiscal 2024 First Quarter Financial Results
7 Nov 23
DEFA14A
Additional proxy soliciting materials
26 Sep 23
DEF 14A
Definitive proxy
26 Sep 23
Transcripts
ELMD
Earnings call transcript
2024 Q2
13 Feb 24
ELMD
Earnings call transcript
2024 Q1
7 Nov 23
ELMD
Earnings call transcript
2023 Q4
22 Aug 23
ELMD
Earnings call transcript
2023 Q3
9 May 23
ELMD
Earnings call transcript
2023 Q2
14 Feb 23
ELMD
Earnings call transcript
2023 Q1
11 Nov 22
ELMD
Earnings call transcript
2022 Q4
24 Aug 22
ELMD
Earnings call transcript
2022 Q3
15 May 22
ELMD
Earnings call transcript
2022 Q2
8 Feb 22
ELMD
Earnings call transcript
2022 Q1
10 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 7.02 mm | 7.02 mm | 7.02 mm | 7.02 mm | 7.02 mm | 7.02 mm |
Cash burn (monthly) | 116.00 k | (no burn) | (no burn) | (no burn) | 81.33 k | (no burn) |
Cash used (since last report) | 775.15 k | n/a | n/a | n/a | 543.49 k | n/a |
Cash remaining | 6.25 mm | n/a | n/a | n/a | 6.48 mm | n/a |
Runway (months of cash) | 53.9 | n/a | n/a | n/a | 79.7 | n/a |
Institutional ownership, Q2 2023
43.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 38 |
Opened positions | 3 |
Closed positions | 3 |
Increased positions | 9 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 20.17 bn |
Total shares | 3.78 mm |
Total puts | 0.00 |
Total calls | 1.50 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Summers Value Fund | 521.69 k | $0.00 |
George H. Winn | 446.30 k | $4.38 mm |
Punch & Associates Investment Management | 417.47 k | $4.47 bn |
Zenith Sterling Advisers | 395.57 k | $4.19 mm |
Vanguard | 361.23 k | $3.87 bn |
Dimensional Fund Advisors | 287.46 k | $3.08 bn |
Acadian Asset Management | 259.07 k | $2.77 mm |
RY Royal Bank Of Canada | 150.13 k | $1.61 bn |
Bridgeway Capital Management | 108.74 k | $1.16 bn |
White Pine Capital | 79.42 k | $850.63 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | James L. Cunniff | Common Stock | Buy | Acquire P | No | No | 15.25 | 9,000 | 137.25 k | 10,000 |
14 Dec 23 | Andrew Summers | Common Stock | Buy | Acquire P | Yes | No | 10.5 | 28,797 | 302.37 k | 351,921 |
1 Dec 23 | Andrea M. Walsh | Common Stock | Grant | Acquire A | No | No | 0 | 3,000 | 0.00 | 12,000 |
1 Dec 23 | Andrew Summers | Common Stock | Grant | Acquire A | No | No | 0 | 3,000 | 0.00 | 6,000 |
1 Dec 23 | Joseph L. Galatowitsch | Common Stock | Grant | Acquire A | No | No | 0 | 3,000 | 0.00 | 9,000 |
Press releases
Electromed, Inc. to Participate in the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
8 Apr 24
Electromed, Inc. to Participate in the 2024 Sidoti March Small-Cap Virtual Conference
28 Feb 24
Electromed, Inc. to Participate in the Virtual 2024 Lytham Partners Investor Select Conference
24 Jan 24